Parexel Marketing/Consulting Business Hurts Third Quarter Earnings
This article was originally published in The Pink Sheet Daily
Executive Summary
The company says revenue fell below expectations due to a staffing shortfall and the timing of a contract with a "key pharmaceutical client." Parexel also faced higher-than-expected costs, which resulted in an earnings warning ahead of its April 21 fiscal third quarter release.